While TGF-β is a canonical inducer of EndMT and fibrosis, its downregulation in our model contrasts with reports of increased TGF-β activity in other cardiovascular disease contexts [18,19,42,43,44]. The gene discussed is TGFB1; the disease is cardiovascular disorder.